| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2019 | A Agilent Technologies, Inc. | Fields Heidi | Director | Sell | 4,000 | $78.56 | $314,256.40 | -35.4% | |
| Sep 17, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $75.38 | $753,801.31 | -53.6% | |
| Sep 17, 2019 | IMDX Insight Molecular Diagnostics Inc. | Arno Andrew | Director | Buy | 50,000 | $2.16 | $108,130.00 | +95.3% | |
| Sep 16, 2019 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 18,593 | $25.66 | $477,088.94 | -22.1% | |
| Sep 13, 2019 | NOTV Inotiv, Inc. | Pitchford William D | Chief Hr Officer | Buy | 12,000 | $3.70 | $44,400.00 | +120.0% | |
| Sep 13, 2019 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 2,271 | $298.00 | $676,758.00 | -0.8% | |
| Sep 13, 2019 | NOTV Inotiv, Inc. | Oakley Daniel Thomas | Chief Operating Officer | Buy | 1,000 | $3.65 | $3,650.00 | +2.1% | |
| Sep 13, 2019 | IMDX Insight Molecular Diagnostics Inc. | Kalajian Tony T | Svp-chief Accounting Officer | Buy | 10,000 | $1.98 | $19,800.00 | New | |
| Sep 13, 2019 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 26,846 | $3.72 | $99,867.12 | +19.4% | |
| Sep 12, 2019 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 838 | $328.29 | $275,104.25 | -2.2% | |
| Sep 12, 2019 | BIO Bio-Rad Laboratories, Inc. | Tumolo Annette71 | Executive Vice President | Sell | 522 | $330.00 | $172,260.00 | -17.8% | |
| Sep 12, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $76.36 | $763,632.50 | -47.4% | |
| Sep 12, 2019 | IMDX Insight Molecular Diagnostics Inc. | Levine Mitchell S | Chief Financial Officer | Buy | 10,000 | $2.01 | $20,060.00 | New | |
| Sep 12, 2019 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 24,635 | $77.50 | $1,909,212.50 | -5.3% | |
| Sep 12, 2019 | EXAS Exact Sciences Corp | Johnson Scott C. | SVP - Research And Development | Sell | 3,527 | $108.63 | $383,138.01 | -22.3% | |
| Sep 11, 2019 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 2,000,000 | $1.66 | $3,320,000.00 | +9.9% | |
| Sep 11, 2019 | GH Guardant Health, Inc. | Svf Bluebird (cayman) Ltd | 10% Owner | Sell | 4,900,000 | $77.00 | $377,300,000.00 | -17.6% | |
| Sep 10, 2019 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 8,000 | $24.51 | $196,114.02 | -2.4% | |
| Sep 10, 2019 | NOTV Inotiv, Inc. | Perrow Wendy | Director | Buy | 10,000 | $3.62 | $36,200.00 | New | |
| Sep 10, 2019 | NEO Neogenomics Inc | Jones Steven C | Director | Sell | 2,894 | $23.54 | $68,114.00 | - | |
| Sep 9, 2019 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 444 | $336.47 | $149,392.68 | -2.4% | |
| Sep 6, 2019 | BIO Bio-Rad Laboratories, Inc. | Tumolo Annette71 | Executive Vice President | Sell | 371 | $340.00 | $126,140.00 | -16.2% | |
| Sep 6, 2019 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 5,195 | $336.57 | $1,748,490.45 | -4.4% | |
| Sep 6, 2019 | NOTV Inotiv, Inc. | Oakley Daniel Thomas | Chief Operating Officer | Buy | 12,500 | $3.43 | $42,925.00 | +15.5% | |
| Sep 4, 2019 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 11,500 | $3.15 | $36,225.00 | +9.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.